


Other types of organizations are highlighted that share some traits as potential early adopters. Known and hypothesized military programs for neuroprosthetic enhancement are discussed, along with characteristics of military organizations that remove obstacles that render the deployment of neuroprostheses impractical for most organizations. It is noted that military organizations play a key role among organizations likely to be early adopters of posthumanizing neuroprostheses. The second path involves retaining human workers in particular positions because exogenous factors (such as legal, ethical, or marketing requirements) mandate that human agents fill them, while augmenting the workers so that they can perform more competitively. First is the ‘transitional augmentation’ of human workers as a stopgap measure on the path to eventual full automation of business processes through the use of AI. Many organizations already unknowingly incorporate workers possessing therapeutic neuroprostheses, while two key paths for the organizational deployment of posthumanizing neuroprostheses are highlighted.

The organizational roles of therapeutic and posthumanizing neuroprostheses are then analyzed. A range of factors incentivizing or discouraging the organizational deployment of posthumanizing neuroprostheses is identified and discussed. The current state of therapeutic neuroprosthetic device use is presented, along with an overview of posthumanizing neuroprostheses and the types of enhanced capacities that they offer human workers that may be relevant to organizations. This text examines the types of organizations that are already working to intentionally deploy neuroprosthetic technologies for human enhancement among their workforce (or are expected to do so), factors that affect their adoption of such technologies, and the organizational roles that such neurotechnologies may play.
